Posted by Michael Wonder on 29 Oct 2019
FDA issues new recommendations to combat drug shortages, but can it really fix the problem?
29 October 2019 - The growing number of drug shortages plaguing the U.S. health care system is due to what federal officials are calling a “broken marketplace.”
And they contend the problem might be fixed with a better understanding of the effect on patients, as well as new incentives for companies to invest in high quality manufacturing facilities.
In a new report, the FDA noted that the number of ongoing shortages has been steadily rising — reaching about 110 — after peaking in 2011 and then declining until last year.
